We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

87 hedge funds and large institutions have $230M invested in Abeona Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $2.29M | Put options by funds: $732K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.11% less ownership

Funds ownership: 2.72% → 2.61% (-0.11%)

1% less capital invested

Capital invested by funds: $232M → $230M (-$2.3M)

12% less funds holding

Funds holding: 99 → 87 (-12)

26% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 31

75% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 16

Holders
87
Holders Change
-12
Holders Change %
-12.12%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
23
Reduced
31
Closed
16
Calls
$2.29M
Puts
$732K
Net Calls
+$1.56M
Net Calls Change
+$1.02M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.95M
2
Millennium Management
Millennium Management
New York
+$1.89M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.04M
4
OM
Opaleye Management
Massachusetts
+$787K
5
BlackRock
BlackRock
New York
+$716K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$5.83M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$2.1M
3
SFM
Sphera Funds Management
Israel
-$1.93M
4
Citigroup
Citigroup
New York
-$1.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$52.9M -$9.3K -52 -0%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$31M +$1.04M +5,833 +4%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$19.1M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$18.4M -$330K -1,848 -2%
KCM
5
Knoll Capital Management
Florida
$17.4M – – –
BlackRock
6
BlackRock
New York
$17.1M +$716K +4,003 +5%
Vanguard Group
7
Vanguard Group
Pennsylvania
$12M +$2.95M +16,524 +34%
BBA
8
Baker Bros. Advisors
New York
$9.48M -$5.83M -32,598 -39%
Millennium Management
9
Millennium Management
New York
$9.35M +$1.89M +10,570 +26%
RPAM
10
Rhenman & Partners Asset Management
Sweden
$4.78M – – –
State Street
11
State Street
Massachusetts
$4.19M +$119K +667 +3%
OM
12
Opaleye Management
Massachusetts
$4.12M +$787K +4,400 +24%
Northern Trust
13
Northern Trust
Illinois
$2.95M -$171K -955 -6%
CAM
14
Cormorant Asset Management
Massachusetts
$2.94M -$633K -3,541 -18%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.79M +$273K +1,525 +11%
SSA
16
Schonfeld Strategic Advisors
New York
$1.61M +$41.5K +232 +3%
Deutsche Bank
17
Deutsche Bank
Germany
$1.37M +$4.11K +23 +0.3%
PA
18
Perceptive Advisors
New York
$1.33M – – –
WM
19
WS Management
Florida
$1.09M -$142K -796 -12%
RA
20
Royce & Associates
New York
$1.05M – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.03M -$179 -1 -0%
AS
22
Altshuler Shaham
Israel
$879K -$52.6K -294 -6%
AA
23
ALPS Advisors
Colorado
$852K +$35.8K +200 +5%
TA
24
Teachers Advisors
New York
$723K – – –
FI
25
Fosun International
China
$719K +$193K +1,080 +38%
1
2 3 4 5

ABEO Hedge Fund Activity: Q1 2019 in Review

87 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2019, worth a combined $230M — down 0.99% from $232M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ABEO and 4 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 23 added.

The largest buyer was Vanguard Group, adding an estimated $2.95M. The largest seller was Baker Bros. Advisors, cutting an estimated $5.83M.

  • 87 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2019, down from 99 in Q4 2018.
  • Funds reported $230M of Abeona Therapeutics stock for Q1 2019, down 0.99% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2019 and 16 closed out, a net change of -12 holders.
  • The largest Abeona Therapeutics buyer in Q1 2019 was Vanguard Group, an estimated $2.95M added.
  • The largest Abeona Therapeutics seller in Q1 2019 was Baker Bros. Advisors, an estimated $5.83M sold.

Based on aggregated 13F filings for Q1 2019.